The in vitro diagnostic “EasyPGX® ready KRAS” kit is intended for the qualitative detection by Real-Time PCR of KRAS somatic mutations in the genomic DNA isolated from tumor tissue (fresh, frozen or formalin fixed paraffin-embedded (FFPE)) or from plasma.
